The assessment of tumour-infiltrating lymphocytes (TILs) and the evaluation of the expression of Programmed Cell Death 1 Ligand 1 (PD-L1) can provide prognostic information and may be valuable in predicting response to immuno-oncological treatments. Here, CD274 is linked to neoplasm.